FNA – ASC Archived Cyto-econferences

Fine Needle Aspiration (FNA)

Click on Item code or Item name to order individual archive

rchive Item Code: 3800-L

Item Name:  The New Diagnostic Paradigms in Follicular Patterned Lesions of the Thyroid and Affects on Reporting of Thyroid Fine-Needle Aspiration Specimens
Zubair W. Baloch, MD, PhD

Presentation date: March 28, 2017; Expires: March 28, 2020
It has been proposed to classify the non-invasive follicular variant of papillary thyroid carcinoma (FVPTC) as “non-invasive follicular thyroid neoplasm with papillary like nuclear features” (NIFT-P). No doubt this change in the name i.e. not calling FVPTC as “carcinoma” can lead to much confusion or add to it. This presentation will discuss the current diagnostic criteria for the follicular patterned lesions of the thyroid and the impact of this reclassification of FVPTC as “not carcinoma” on the reporting of thyroid FNA specimens.


rchive Item Code: 3800-K

Item Name:  Role of Fine Needle Aspiration in the Diagnosis of Hematopoietic Lesions
Rana S. Hoda, MD, FIAC and Scott Ely, MD

Presentation date: February 28, 2017; Expires: February 28, 2020
Lymphoma is commonly encountered in fine needle aspiration (FNA) cytology. The diagnosis and sub-classification of non-Hodgkin lymphoma, particularly, low-grade lymphomas, can be extremely difficult in cytology. The main reasons being morphological overlap between the various types of low-grade lymphomas, difficulty of distinguishing these lymphomas from benign lymphoid process and inappropriate triage of FNA sample. The strength of this interactive conference is its combination of a cytopathologist and hematopathologist, both experts in their field, to discuss their approach to and address the challenges of diagnosing lymphoma. Current lymphoma classification, reporting terminology and pertinent treatment will be also be addressed. Participants attending this session will walk away knowing precisely how to diagnose and sign out the various types of lymphomas.


rchive Item Code: 3800-I

Item Name:  The Milan System and Other Aspects of Salivary Gland Cytology
William C. Faquin, MD, PhD

Presentation date: December 13, 2016; Expires: December 13, 2019
Salivary gland cytology represents one of the most challenging areas of cytopathology due to the diverse array of both benign and malignant tumors, many with overlapping microscopic features. This session will familiarize the audience with key cytologic features of many of the more common as well as challenging salivary gland tumors. An emphasis will be placed on the avoidance of certain diagnostic pitfalls, and the application of selected ancillary tests (cytochemical, immunologic, and molecular markers) will be reviewed. Finally, an overview of the newly proposed Milan System for Reporting Salivary Gland Cytopathology will be presented.


rchive Item Code: 3800-H

Item Name:  Systematic Approach to FNA Diagnosis of Metastatic Neoplasms
Yun Gong, MD

Presentation date: November 22, 2016; Expires: November 22, 2019
This presentation provides a road map with which to navigate the thought process in reaching a proper final FNA diagnosis. The main framework of diagnostic approach includes metastatic pattern, morphologic pattern, and immunophenotypic pattern. A systematic, tired algorithm is well outlined in immunoperoxidase workup. The pitfalls or traps that may be encountered in daily practice are emphasized and the solutions or tips are provided.


rchive Item Code: 3800-G

Item Name:  Cytopathologist Ultrasound Guided (US) FNA
Susan D. Rollins, MD, FCAP, FIAC and Rosemary Tambouret, MD

Presentation date: October 25, 2016; Expires: October 25, 2019
Cytopathologist performed USFNA streamlines and increases the sensitivity and specificity of the FNA procedure and makes more lesions accessible to the cytopathologist for biopsy. Participants will learn the benefits of cytologist-performed USFNA, understand the pre-requisition needed to perform USFNA, see patient examples of USFNA and learn basic ultrasound terminology related to image interpretation.


rchive Item Code: 3800-D

Item Name:  Role of Touch Imprint Cytology of Needle Core Biopsies in Adequacy Assessment: Change in Practice Pattern
Vijayalakshmi Padmanabhan, MD

Presentation date: July 26, 2016; Expires: July 26, 2019
Needle core biopsies (NCB) are replacing classic FNA in many institutions across the US, and intra-procedural cytological assessment of the Touch Imprint (TI) cytology of NCB is often requested by radiologists. In this webinar, we will discuss the role of TI cytology of skinny NCB in adequacy assessment – preparing the specimen, differentiating the morphological features from classic FNA and the advantages and pitfalls of this technique.


rchive Item Code: 3800-B

Item Name:  The 2015 American Thyroid Association Management Guidelines for Thyroid Nodules: Implications for Fine-Needle Aspiration and Cytology Practice
Mary C. Frates, MD and Jeffrey F. Krane, MD, PhD

Presentation date: May 24, 2016; Expires: May 24, 2019
This presentation will review the 2015 American Thyroid Association management guidelines for thyroid nodules. In particular, an approach to the decision for fine needle aspiration will be presented based on nodule size and sonographic characteristics. Indications for repeat aspiration will also be described. Appropriate management of cytologically indeterminate nodules, including the role of molecular testing, will also be emphasized.


rchive Item Code: 3700-L

Item Name:  Diagnosis of Primary Bone Neoplasms by FNA and Core Needle Biopsy: A Practical and Multidisciplinary Approach
Xiaohua Qian, MD, PhD

Presentation date: March 22, 2015; Expires: March 22, 2018
A practical and multidisciplinary approach to the diagnosis of various primary bone tumors will be presented. This case-based webinar will cover both common and uncommon entities, including osteogenetic, cartilaginous, giant cell-rich, and small round cell tumors. The importance of radiologic correlation and an awareness of diagnostic pitfalls will be emphasized. The webinar will be grounded in the current WHO classification of bone tumors and will incorporate an update on recent molecular advances in the field.


Archive Item Code: 3700-H

Item Name: Fine Needle Aspiration Cytology of the Kidney: Current Role, Morphological Analysis, and Diagnostic Dilemmas
Laura Tabatabai, MD

Presentation date: November 24, 2015; Expires: November 24, 2018
Renal fine needle aspiration biopsy has become a less common procedure in the era of advanced imaging techniques, however, it remains a useful diagnostic tool in selected clinical settings. In this webinar, the current role of renal FNA in the assessment and management of patients with kidney masses will be discussed. The cytomorphological criteria and differential diagnosis of select common and uncommon tumors of the kidney including diagnostic dilemmas and potential pitfalls will be presented, and updates and limitations in ancillary testing will be reviewed.


Archive Item Code:

Item Name: A Walk Around the Block
Donna K. Russell, MEd, CT(ASCP)HT

Presentation Date: May 26, 2015; Expires: May 26, 2018
Update your knowledge of body fluids and image-guided fine needle aspirations from a cytotechnology professional engaged in immediate assessment and specimen triage. The webinar will have you recognize the importance of cell block preparation. Radiologic findings, clinical history and cytologic criteria will be presented from a variety of contemporary image-guided techniques. Case studies from a variety of techniques will be discussed, along with ancillary testing. Techniques include endoscopic ultrasound-guided FNA, Super Dimension bronchial FNA, Cat-scan image-guided FNA and ultrasound-guided fine needle aspiration. This webinar will allow participants to interact with each case presented. The cases will include clinical history, radiologic findings and cytologic criteria. After the votes are in, the participants will then comment on the correct interpretation using an audience response system. The correct interpretation along with surgical pathology or additional ancillary testing will be provided for each case.


Archive Item Code: 3700-C

Item Name: The Challenge of Ensuring Adequacy in the Era of Targeted Lung Cancer Therapy
John M. Stewart, MD, PhD and Michael J. Thrall, MD

Presentation date: June 23, 2015; Expires: June 23, 2018
In recent years, therapeutic options for lung cancer have markedly expanded. While this offers new hope for patients, it also places an increasing burden on cytologists who now need to provide more information about the type of carcinoma they are examining while preserving cells for vitally important molecular ancillary testing. This webinar will provide insights into best practices for getting the most of limited cytology and small biopsy material. In particular, touch preparation triage of CT-guided biopsies, evaluation of cell blocks for molecular testing adequacy, and evaluation of endobronchial ultrasound-guided FNA material will be discussed.






Archive Item Code: 3600-K

Item Name: Telecytopathology: Opportunities and Challenges
Brian T. Collins, MD

Presentation date: February 24, 2015; Expires: February 24, 2018
Telecytopathology is an exciting and emerging digital image service involving technologies which enable the cytopathology service to provide on-site immediate interpretation of FNA biopsies. It is becoming easier to implement and deploy systems utilizing currently available hardware and software solutions. Growing demands on health care providers will encourage more efficient use of the time required for managing and evaluating FNA biopsies. The specific hardware and software solutions available will be discussed. Plans for acquisition, validation, implementation, and work flow considerations will be covered. An overview of the current state of the art will be provided.


Archive Item Code: 3600-L

Item Name: Diagnostic Difficulties in Pulmonary Cytology and Optimal Use of Ancillary Testing
Hormoz Ehya, MD

Presentation date: March 24, 2015; Expires: March 24, 2018
Major diagnostic difficulties in pulmonary cytology include the differential diagnosis of benign/reactive conditions versus carcinoma and classification of neoplasms.  The new targeted therapies require accurate classification of lung tumors. Improved survival in cancer patients has led to the increased occurrence of second and third primaries, necessitating the use of immunocytochemical stains to determine the primary source. Furthermore, the increasing need for molecular studies mandates prudent use of immunostains in order to conserve tissue. In this webinar the morphologic criteria to distinguish benign from malignant lesions and appropriate use of immunostains in the differential diagnosis of lung tumors will be discussed.